IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained
Journal of Endocrinology · 2024
DOI: 10.1530/joe-24-0058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Jane Stremming und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Insulin, Fetal Development. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
Insulin-like growth factor 1 (IGF-1) is a critical fetal anabolic hormone. IGF-1 infusion to the normally growing sheep fetus increases the weight of some organs but does not consistently increase body weight. However, IGF-1 infusion profoundly decreases fetal plasma insulin concentrations, which may limit fetal growth potential. In this study, normally growing late-gestation fetal sheep received an intravenous infusion of either: IGF-1 (IGF), IGF-1 with insulin and dextrose to maintain fetal euinsulinemia and euglycemia (IGF+INS), or vehicle control (CON) for 1 week. The fetus underwent a metabolic study immediately prior to infusion start and after 1 week of the infusion to measure uterine and umbilical uptake rates of nutrients and oxygen. IGF+INS fetuses were 23% heavier than CON ( P = 0.0081) and had heavier heart, liver, and adrenal glands than IGF and CON ( P < 0.01). By design, final fetal insulin concentrations in IGF were 62% and 65% lower than IGF+INS and CON, respectively. Final glucose concentrations were similar in all groups. IGF+INS had lower final oxygen content than IGF and CON ( P < 0.0001) and lower final amino acid concentrations than CON ( P = 0.0002). Final umbilical oxygen uptake was higher in IGF+INS compared to IGF and CON ( P < 0.05). Final umbilical uptake of several essential amino acids was higher in IGF+INS compared to CON ( P < 0.05). In summary, maintaining euinsulinemia and euglycemia during fetal IGF-1 infusion is necessary to maximally support body growth. We speculate that IGF-1 and insulin stimulate placental nutrient transport to support fetal growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Jane Stremming, Eileen I Chang
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- NIH HHS
Zitieren
APA
Stremming, J., Chang, E. I., White, A., Rozance, P. J., & Brown, L. D. (2024). IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained. Journal of Endocrinology. https://doi.org/10.1530/joe-24-0058
Vancouver
Stremming J, Chang EI, White A, Rozance PJ, Brown LD. IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained. Journal of Endocrinology. 2024. doi:10.1530/joe-24-0058
BibTeX
@article{Stremming2024,
author = {Stremming, Jane and Chang, Eileen I and White, Alicia and Rozance, Paul J and Brown, Laura D},
title = {IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained},
journal = {Journal of Endocrinology},
year = {2024},
doi = {10.1530/joe-24-0058}
}
EUVIMED